Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 238 (RNA5SP238)

Target: RNA5SP238
Molecular classification: Pseudogene, Non-coding RNA (ncRNA)

Overview

RNA, 5S ribosomal pseudogene 238 (RNA5SP238) is a human pseudogene related to the 5S ribosomal RNA gene[1][2][4]. Pseudogenes are genetic elements that resemble functional genes but have lost their protein-coding or RNA-coding capacity due to mutations or loss of regulatory elements. The 5S ribosomal RNA itself is a structural component of the large ribosomal subunit and is essential for ribosome function in protein synthesis; however, RNA5SP238 is classified as a non-coding pseudogene and does not encode a functional RNA product[1][2][5]. Most pseudogenes, including RNA5SP238, have no direct, well-established role in normal physiology or as therapeutic drug targets, though the expression of some pseudogenes can contribute to gene regulatory networks or serve as disease biomarkers in specific contexts such as cancer[6]. There are no known drugs directly interacting with or targeting this pseudogene[1][4][6].

Other names: RN5S238RNA5SP238RNA, 5S ribosomal 238

Biological functions

Pseudogenes typically do not have direct biological functions through protein/RNA activity; however, some pseudogenes can regulate their parent genes or participate in RNA regulatory networks, sometimes acting as competitive endogenous RNAs or lncRNAs[6].

Disease associations

Other (Limited: While some pseudogenes can be involved in cancer mechanisms or serve as biomarkers through their expression profiles, there is no specific evidence linking RNA5SP238 directly to a disease)[6].

Biomarkers

Other (Generally, pseudogene expression can sometimes serve as a prognostic biomarker in cancer settings, but there is no documentation for RNA5SP238 specifically)[6].

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 238 (RNA5SP238).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 238 (RNA5SP238).

Explore the full profile